IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 11,648

Sort by:

Androgen Insensitivity Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major androgen insensitivity syndrome markets reached a value of US$ 378.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 633.1 Million by 2034, exhibiting a growth r...

May 2024 133 pages

Androgenetic Alopecia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major androgenetic alopecia markets reached a value of US$ 1,737.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,637.1 Million by 2034, exhibiting a growth rate (C...

May 2024 136 pages

Anemia in Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The anemia in chronic kidney disease market has been comprehensively analyzed in IMARC's new report titled 'Anemia in Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth,...

May 2024 131 pages

Anemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anemia markets reached a value of US$ 7.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 12.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.91% during 2...

May 2024 129 pages

Aneurysmal Subarachnoid Hemorrhage Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major aneurysmal subarachnoid hemorrhage markets reached a value of US$ 245.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 331.9 Million by 2034, exhibiting a growt...

May 2024 135 pages

Angelman Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Angelman syndrome markets reached a value of US$ 105.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 165.6 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 128 pages

Angina Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major angina markets reached a value of US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 10.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3.7% during 20...

May 2024 137 pages

Angioedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major angioedema markets are expected to exhibit a CAGR of 6.99% during 2024-2034. The angioedema market has been comprehensively analyzed in IMARC's new report titled 'Angioedema Market: Epidem...

May 2024 137 pages

Ankylosing Spondylitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ankylosing spondylitis markets reached a value of US$ 4.8 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 9.3 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Anorexia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anorexia markets reached a value of US$ 88.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 556.6 Million by 2034, exhibiting a growth rate (CAGR) of 18.14% dur...

May 2024 134 pages

Anovulation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anovulation markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR) of 12.29% dur...

May 2024 135 pages

Anterior Uveitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anterior uveitis markets reached a value of US$ 195.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 316.0 Million by 2034, exhibiting a growth rate (CAGR) of 4...

May 2024 128 pages

Anti-Hypertension Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anti-hypertension markets are expected to exhibit a CAGR of 2.13% during 2024-2034. The anti-hypertension market has been comprehensively analyzed in IMARC's new report titled 'Anti-Hypert...

May 2024 138 pages

Antibody-Mediated Rejection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major antibody-mediated rejection markets reached a value of US$ 112.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 401.8 Million by 2034, exhibiting a growth rate...

May 2024 130 pages

Antiphospholipid Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major antiphospholipid syndrome markets reached a value of US$ 29.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 74.5 Million by 2034, exhibiting a growth rate (CAG...

May 2024 128 pages

Anxiety Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major anxiety disorders markets reached a value of US$ 8.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.3...

May 2024 129 pages

Appendicitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major appendicitis markets are expected to exhibit a CAGR of 4.1% during 2024-2034. The appendicitis market has been comprehensively analyzed in IMARC's new report titled 'Appendicitis Market: E...

May 2024 129 pages

Apraxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major apraxia markets are expected to exhibit a CAGR of 3% during 2024-2034. The apraxia market has been comprehensively analyzed in IMARC's new report titled 'Apraxia Market: Epidemiology, Indu...

May 2024 136 pages

Arbovirus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034?

US$ 6,499.00

The 7 major arbovirus infection markets are expected to exhibit a CAGR of 5.56% during 2024-2034. The arbovirus infection market has been comprehensively analyzed in IMARC's new report titled 'Arbovir...

May 2024 139 pages

Argininosuccinic Aciduria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major argininosuccinic aciduria markets are expected to exhibit a CAGR of 3.3% during 2024-2034. The argininosuccinic aciduria market has been comprehensively analyzed in IMARC's new report titl...

May 2024 140 pages

Arteriovenous Fistula Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major arteriovenous fistula markets reached a value of US$ 253.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 412.6 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 133 pages

Arteriovenous Malformations Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major arteriovenous malformations markets are expected to exhibit a CAGR of 6.1% during 2024-2034. The arteriovenous malformations market has been comprehensively analyzed in IMARC's new report...

May 2024 137 pages

Arthralgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major arthralgia markets reached a value of US$ 4.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.5 Billion by 2034, exhibiting a growth rate (CAGR) of 6.12% durin...

May 2024 134 pages

Ascites Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ascites markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.6 Billion by 2034, exhibiting a growth rate (CAGR) of 3.46% during 2...

May 2024 140 pages

Asherman's Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Asherman's syndrome markets reached a value of US$ 182.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 315.0 Million by 2034, exhibiting a growth rate (CAGR) o...

May 2024 139 pages

Asperger Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major asperger syndrome markets are expected to exhibit a CAGR of 2.84% during 2024-2034. The Asperger syndrome market has been comprehensively analyzed in IMARC's new report titled 'Asperger Sy...

May 2024 131 pages

Aspergillosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major aspergillosis markets reached a value of US$ 2.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.69% du...

May 2024 134 pages

Asphyxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major asphyxia markets are expected to exhibit a CAGR of 11.36% during 2024-2034. The asphyxia market has been comprehensively analyzed in IMARC's new report titled 'Asphyxia Market: Epidemiolog...

May 2024 138 pages

Asphyxia Neonatorum Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major asphyxia neonatorum markets are expected to exhibit a CAGR of 10.2% during 2024-2034. The asphyxia neonatorum market has been comprehensively analyzed in IMARC's new report titled 'Asphyxi...

May 2024 134 pages

Astigmatism Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major astigmatism markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.49% duri...

May 2024 135 pages

Astrocytoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major astrocytoma markets are expected to exhibit a CAGR of 4.4% during 2024-2034. The astrocytoma market has been comprehensively analyzed in IMARC's new report titled 'Astrocytoma Market: Epid...

May 2024 137 pages

Ataxia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ataxia markets reached a value of US$ 23.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 43.1 Billion by 2034, exhibiting a growth rate (CAGR) of 5.49% during...

May 2024 129 pages

Ataxia Telangiectasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major ataxia telangiectasia markets reached a value of US$ 585.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,270.2 Million by 2034, exhibiting a growth rate (CAG...

May 2024 135 pages

Atherosclerosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major atherosclerosis markets reached a value of US$ 14.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 18.6 Billion by 2034, exhibiting a growth rate (CAGR) of 2.15...

May 2024 137 pages

Atherosclerotic Cardiovascular Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major atherosclerotic cardiovascular disease markets reached a value of US$ 23.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 29.7 Billion by 2034, exhibiting a gro...

May 2024 139 pages

Athlete's Foot Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major athlete's foot markets reached a value of US$ 675.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 860.5 Million by 2034, exhibiting a growth rate (CAGR) of 2.2...

May 2024 133 pages

Atrial Flutter Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major atrial flutter markets are expected to exhibit a CAGR of 4.7% during 2024-2034. The atrial flutter market has been comprehensively analyzed in IMARC's new report titled 'Atrial Flutter Mar...

May 2024 130 pages

Attention Deficit Hyperactivity Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major attention deficit hyperactivity disorder markets reached a value of US$ 9.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 13.6 Billion by 2034, exhibiting a gr...

May 2024 134 pages

Autism Spectrum Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major autism spectrum disorder markets are expected to exhibit a CAGR of 5.31% during 2024-2034. The autism spectrum disorder market has been comprehensively analyzed in IMARC's new report title...

May 2024 132 pages

Autoimmune Hepatitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major autoimmune hepatitis markets reached a value of US$ 115.3 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 156.9 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 134 pages

Avascular Necrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major avascular necrosis markets reached a value of US$ 465.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 763.3 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 129 pages

Axial Spondylarthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major axial spondylarthritis markets reached a value of US$ 6.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.1 Billion by 2034, exhibiting a growth rate (CAGR) o...

May 2024 137 pages

Axillary Hyperhidrosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major axillary hyperhidrosis markets reached a value of US$ 1.2 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.1 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 138 pages

B Cell Chronic Lymphocytic Leukemia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major B cell chronic lymphocytic leukemia markets are expected to exhibit a CAGR of 4.62% during 2024-2034. The B cell chronic lymphocytic leukemia market has been comprehensively analyzed in IM...

May 2024 131 pages

B-Cell Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major B-cell lymphoma markets reached a value of US$ 4.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.6 Billion by 2034, exhibiting a growth rate (CAGR) of 5.64%...

May 2024 139 pages

B-Cell Non-Hodgkin Lymphoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major B-cell non-Hodgkin lymphoma markets are expected to exhibit a CAGR of 5.83% during 2024-2034. The B-cell non-Hodgkin lymphoma market has been comprehensively analyzed in IMARC's new report...

May 2024 129 pages

Bacterial Conjunctivitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bacterial conjunctivitis markets reached a value of US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.3 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 137 pages

Bacterial Pneumonia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bacterial pneumonia markets reached a value of US$ 2.0 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.6 Billion by 2034, exhibiting a growth rate (CAGR) of 5....

May 2024 128 pages

Bacterial Skin Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bacterial skin diseases markets are expected to exhibit a CAGR of 6.56% during 2024-2034. The bacterial skin diseases market has been comprehensively analyzed in IMARC's new report titled...

May 2024 137 pages

Bacterial Vaginosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major bacterial vaginosis markets reached a value of US$ 762.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,405.4 Million by 2034, exhibiting a growth rate (CAGR)...

May 2024 140 pages

Filters

Clear all